Abstract
Globally, ischaemic heart disease is the leading cause of death, with a higher mortality burden amongst older adults. Although advancing age is associated with a higher risk of adverse outcomes following acute coronary syndrome (ACS), older patients are less likely to receive evidence-based medications and coronary angiography. Guideline recommendations for managing ACS are often based on studies that exclude older patients, and more contemporary trials have been underpowered and produced inconsistent findings. There is also limited evidence for how frailty and comorbidity should influence management decisions. This review focuses on the current evidence base for the medical and percutaneous management of ACS in older patients and highlights the distinct need to enrol older patients with ACS into well-powered, large-scale randomized trials.
| Original language | English |
|---|---|
| Article number | oeab044 |
| Number of pages | 14 |
| Journal | European heart journal open |
| Volume | 2 |
| Issue number | 1 |
| Early online date | 17 Dec 2021 |
| DOIs | |
| Publication status | Published - 11 Jan 2022 |
Bibliographical note
© The Author(s) 2021Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver